Ignite Creation Date:
2024-05-05 @ 4:37 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00276679
Status:
COMPLETED
Last Update Posted:
2013-09-17
First Post:
2006-01-12
Brief Title:
Temozolomide in Treating Young Patients With High-Risk Relapsed or Refractory Neuroblastoma
Sponsor:
Childrens Cancer and Leukaemia Group
Organization:
National Cancer Institute NCI